Mortality of Sepsis in Swedish Intensive Care Units 2008-2016
NCT ID: NCT03489447
Last Updated: 2018-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
252245 participants
OBSERVATIONAL
2008-01-01
2017-10-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit
NCT05924126
Evaluation of the Prognostic Value of Immature Platelet Fraction
NCT07039227
Shock Indices Use for Early Mortality From Septic Shock
NCT05088109
Sepsis at Södersjukhuset-Adherence to Treatment Guidelines
NCT04055727
Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit
NCT03217721
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Mortality, adjusted for severity of illness, comorbidity and patient factors, is studied and any changes over time during the inclusion period are assessed.
The data in the Swedish ICU Registry are entered by the treating ICU physicians and include severity of illness (Simplified Acute Physiology Score (SAPS)3), selected chronic comorbidity, sex and date of birth, ICU stay and selected interventions and complications. Relevant International Classification of Diseases (ICD)-10 diagnoses are required and assessment of the occurrence of severe sepsis or septic shock, during the inclusion period defined according to the American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) (sepsis 2) criteria, is mandatory when entering data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sepsis group
All adult (\>= 18 years) patients with a diagnosis of sepsis included in the Swedish ICU Registry between 2008-01-01 and 2016-10-18
ICU care
exposure to ICU treatment with or without diagnosed sepsis
Non-sepsis group
All adult (\>=18 years) patients without a diagnosis of sepsis included in the Swedish ICU Registry between 2008-01-01 and 2016-10-18
ICU care
exposure to ICU treatment with or without diagnosed sepsis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ICU care
exposure to ICU treatment with or without diagnosed sepsis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Episode registered in Swedish Intensive Care Registry
Exclusion Criteria
* Readmission (only first episode during the period included)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miklós Lipcsey, PhD
Role: PRINCIPAL_INVESTIGATOR
Uppsala University
References
Explore related publications, articles, or registry entries linked to this study.
Strandberg G, Walther S, Agvald Ohman C, Lipcsey M. Mortality after Severe Sepsis and Septic Shock in Swedish Intensive Care Units 2008-2016-A nationwide observational study. Acta Anaesthesiol Scand. 2020 Aug;64(7):967-975. doi: 10.1111/aas.13587. Epub 2020 Apr 27.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015/519
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.